BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2758565)

  • 1. Ifosfamide in the treatment of pediatric malignancies. 4th European Conference on Clinical Oncology and Cancer Nursing. Madrid, November 1987. Proceedings.
    Cancer Chemother Pharmacol; 1989; 24 Suppl 1():S1-51. PubMed ID: 2758565
    [No Abstract]   [Full Text] [Related]  

  • 2. Ifosfamide in gynecological tumors. Satellite symposium of 5th European Conference on Clinical Oncology and Cancer Nursing. London, September 3-7, 1989. Proceedings.
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S1-102. PubMed ID: 2347044
    [No Abstract]   [Full Text] [Related]  

  • 3. Recent experience with ifosfamide/mesna in solid tumors. International satellite symposium to the 3rd European Conference on Clinical Oncology. Stockholm, June 1985. Proceedings.
    Cancer Chemother Pharmacol; 1986; 18 Suppl 2():S1-58. PubMed ID: 3102087
    [No Abstract]   [Full Text] [Related]  

  • 4. Interferon therapy--molecular mechanisms and clinical applications. Proceedings of a satellite symposium held at the 4th European Conference on Clinical Oncology and Cancer Nursing. Madrid, Spain, 1st-4th November 1987.
    Br J Clin Pract Suppl; 1988 Mar; 62():1-26. PubMed ID: 2462897
    [No Abstract]   [Full Text] [Related]  

  • 5. Current developments and future direction with ifosfamide. Proceedings of a satellite symposium of the European Society of Medical Oncology. October 31, 1988, Lugano, Switzerland.
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):1-101. PubMed ID: 2704999
    [No Abstract]   [Full Text] [Related]  

  • 6. Ongoing clinical studies of ifosfamide for pediatric cancer in the United States.
    Pratt CB
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):84-90. PubMed ID: 8677456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in ifosfamide chemotherapy. Proceedings of a symposium. November 4-5, 1989, Key Biscayne, FL.
    Semin Oncol; 1990 Apr; 17(2 Suppl 4):1-79. PubMed ID: 2333523
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ifosfamide in pediatric malignancy--experiences in the Northern Israel Oncology Center].
    Roguin A; Ben Arush MW; Higasi A; Kuten A
    Harefuah; 1996 Apr; 130(8):511-4, 584. PubMed ID: 8765870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Papers presented at ECCO-4. 4th European Conference on Clinical Oncology and Cancer Nursing. Madrid, Nover 1-4, 1987.
    Acta Oncol; 1988; 27(5):465-589. PubMed ID: 3203004
    [No Abstract]   [Full Text] [Related]  

  • 10. Response of pediatric malignant solid tumors following ifosfamide or ifosfamide/carboplatin/etoposide: a single hospital experience.
    Pratt CB; Luo X; Fang L; Marina N; Avery L; Furman WL
    Med Pediatr Oncol; 1996 Sep; 27(3):145-8. PubMed ID: 8699990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotoxicity during ifosfamide treatment in children.
    Di Cataldo A; Astuto M; Rizzo G; Bertuna G; Russo G; Incorpora G
    Med Sci Monit; 2009 Jan; 15(1):CS22-5. PubMed ID: 19114973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ifosfamide in pediatric oncology.
    de Kraker J
    Anticancer Drugs; 1991 Aug; 2(4):339-41. PubMed ID: 1797190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current developments and future directions with ifosfamide: an update. Proceedings of a satellite symposium of the XV Congress of the European Society for Medical Oncology. Copenhagen, Denmark, December 2, 1990.
    Semin Oncol; 1992 Feb; 19(1 Suppl 1):1-77. PubMed ID: 1357753
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ifosfamide treatment for children with malignant tumor].
    Muchi H; Taniguchi Y; Makino S
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3291-4. PubMed ID: 3688893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proceedings of a symposium on ifosfamide (Mitoxana; Holoxan) and Mesna (Uromitexan). Coventry, U.K., 16-18 March 1983.
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():1-192. PubMed ID: 6414687
    [No Abstract]   [Full Text] [Related]  

  • 16. Ifosfamide and Mesna in advanced malignancies.
    Li GC; Brock N; Li JQ; Guan ZZ; He YJ
    Chin Med J (Engl); 1988 Mar; 101(3):213-20. PubMed ID: 3136996
    [No Abstract]   [Full Text] [Related]  

  • 17. Discussion: the Satellite Symposium on "Ifosfamide in the treatment of sarcomas" of the 6th European Conference on Clinical Oncology and Cancer Nursing, Firenze, October 27, 1991.
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S244-9. PubMed ID: 8095860
    [No Abstract]   [Full Text] [Related]  

  • 18. Ifosfamide in the treatment of breast cancer.
    Overmoyer BA
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):38-41. PubMed ID: 8677447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nephropathy in patients treated with ifosfamide].
    Kiss K; Nagy K; Hunyadi K; Simkó R
    Orv Hetil; 1994 May; 135(19):1023-6. PubMed ID: 8183542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of cell therapy as a means of targeting chemotherapy to inoperable pancreatic cancer.
    Günzburg WH; Salmons B
    Acta Biochim Pol; 2005; 52(3):601-7. PubMed ID: 16175235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.